What Changed
Price Move History
- Daily moves over 5%
- 44 68 sessions, January 21, 2026 to October 6, 2026
- Largest daily move
- +150.2% close of January 30, 2026
Company Description
MindBio Therapeutics (OTC: MBQIF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $436.5K.
This page collects what Stock Titan holds for MBQIF, including price data, latest news, and short interest trends.
Stock Performance
MindBio Therapeutics (MBQIF) closed at $0.0451 on October 6, 2026.
MBQIF Metrics & Rankings
Price returns through October 6, 2026. Ranking links may use different dates.
Latest News
MindBio Therapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include AI. View all MBQIF news →
SEC Filings
Short Interest History
Short interest in MindBio Therapeutics (MBQIF) currently stands at 426 shares, down 21.3% from the previous reporting period, representing 0.0% of the float. Since January 2026, short interest has decreased by 19.6%.
Days to Cover History
Days to cover for MindBio Therapeutics (MBQIF) currently stands at 2.1 days, up 112% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since January 2026, the figure has increased by 112%. Across the settlements charted above, it has ranged from 1.0 to 3.6 days.
MBQIF Company Profile & Sector Positioning
MindBio Therapeutics (MBQIF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MBQIF often look at related companies in the same sector, including Orgenesis Inc (ORGS), Regenerative Medical Tech (RMTG), Mosaic ImmunoEngineering (CPMV), Altamira Therapeutics Ltd (CYTOF), and CNBX Pharmaceutical Inc (CNBX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MBQIF's relative position within its industry.